Product image of Voncento (Human Coagulation Factor Viii, Human Von Willebrand Factor) supplied by GNH India

Voncento

Active Ingredient:
Human Coagulation Factor Viii, Human Von Willebrand Factor
Origin:
EU

Voncento (Human Coagulation Factor Viii, Human Von Willebrand Factor)

Voncento combines human coagulation Factor VIII and von Willebrand Factor for hemophilia A and von Willebrand disease management. This intravenous therapy supports clotting factor replacement under medical supervision. Ideal for patients seeking reliable clotting support.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Voncento is used to control and prevent bleeding episodes in patients with hemophilia A and von Willebrand disease. It replaces missing or deficient clotting factors to promote normal blood clotting. Healthcare providers may prescribe it for routine prophylaxis or on-demand treatment. Always follow a physician’s guidance for appropriate use.

Side Effects

  • Voncento works by supplying the body with the necessary clotting factors to help blood clot properly. After administration, patients may experience improved clotting function and reduced bleeding episodes. Individual responses vary based on condition and treatment plan.

Precautions & Warnings

  • Store Voncento as directed, typically refrigerated but protected from freezing. Protect the product from light and avoid shaking the vial. Always check the solution for particles or discoloration before use. Discard any unused portion as recommended by healthcare guidelines.

Avoid Interactions

  • Voncento may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Inform your healthcare provider about all medications and supplements you are taking. Avoid combining Voncento with therapies that could increase bleeding risk without medical supervision.

Frequently Asked Questions

Voncento is used to treat and prevent bleeding in patients with hemophilia A and von Willebrand disease by replacing missing clotting factors.

Voncento is given as an intravenous infusion under the supervision of a healthcare professional.

Voncento is specifically intended for bleeding related to hemophilia A and von Willebrand disease; consult a doctor for other bleeding conditions.

Safety during pregnancy should be determined by a healthcare provider based on individual medical needs.

Voncento is available through licensed pharmacies and medical suppliers; consult a healthcare provider for prescription requirements.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii, Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT